AVITA Medical, Inc. 51KA.F Stock
AVITA Medical, Inc. Price Chart
AVITA Medical, Inc. 51KA.F Financial and Trading Overview
| AVITA Medical, Inc. stock price | 9.5 EUR |
| Previous Close | 15.1 EUR |
| Open | 15.3 EUR |
| Bid | 15.3 EUR x N/A |
| Ask | 15.8 EUR x N/A |
| Day's Range | 15.3 - 15.3 EUR |
| 52 Week Range | 4.3 - 15.7 EUR |
| Volume | 345 EUR |
| Avg. Volume | 11 EUR |
| Market Cap | 389.82M EUR |
| Beta (5Y Monthly) | 1.027586 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.31 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 40.6 EUR |
51KA.F Valuation Measures
| Enterprise Value | 1.92B EUR |
| Trailing P/E | N/A |
| Forward P/E | -11.860466 |
| PEG Ratio (5 yr expected) | -0.23 |
| Price/Sales (ttm) | 10.414194 |
| Price/Book (mrq) | 25 |
| Enterprise Value/Revenue | 51.204 |
| Enterprise Value/EBITDA | -69.979 |
Trading Information
AVITA Medical, Inc. Stock Price History
| Beta (5Y Monthly) | 1.027586 |
| 52-Week Change | 256.81% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 15.7 EUR |
| 52 Week Low | 4.3 EUR |
| 50-Day Moving Average | 12.82 EUR |
| 200-Day Moving Average | 8.64 EUR |
51KA.F Share Statistics
| Avg. Volume (3 month) | 11 EUR |
| Avg. Daily Volume (10-Days) | 64 EUR |
| Shares Outstanding | 25.33M |
| Float | 113.57M |
| Short Ratio | N/A |
| % Held by Insiders | 1.26% |
| % Held by Institutions | 18.04% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -70.58% |
| Operating Margin (ttm) | -74.61% |
| Gross Margin | 84.15% |
| EBITDA Margin | -73.17% |
Management Effectiveness
| Return on Assets (ttm) | -17.53% |
| Return on Equity (ttm) | -30.13% |
Income Statement
| Revenue (ttm) | 37.43M EUR |
| Revenue Per Share (ttm) | 0.3 EUR |
| Quarterly Revenue Growth (yoy) | 39.90% |
| Gross Profit (ttm) | 28.38M EUR |
| EBITDA | -27389000 EUR |
| Net Income Avi to Common (ttm) | -26422000 EUR |
| Diluted EPS (ttm) | -0.98 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 73.45M EUR |
| Total Cash Per Share (mrq) | 0.58 EUR |
| Total Debt (mrq) | 1.87M EUR |
| Total Debt/Equity (mrq) | 2.42 EUR |
| Current Ratio (mrq) | 7.205 |
| Book Value Per Share (mrq) | 0.612 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -18793000 EUR |
| Levered Free Cash Flow (ttm) | -7542125 EUR |
Profile of AVITA Medical, Inc.
| Country | Germany |
| State | CA |
| City | Valencia |
| Address | 28159 Avenue Stanford |
| ZIP | 91355 |
| Phone | 661 367 9170 |
| Website | https://www.avitamedical.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 126 |
AVITA Medical, Inc. operates as a regenerative medicine company in the United States, Australia, Japan, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's skin. Its lead product is RECELL System, a platform technology allows for the preparation and delivery of spray-on skin cells to regenerate natural healthy epidermis, as well as to use in the treatment of acute thermal burns in patients eighteen years and older. AVITA Medical, Inc. has a research agreement with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.
Q&A For AVITA Medical, Inc. Stock
What is a current 51KA.F stock price?
AVITA Medical, Inc. 51KA.F stock price today per share is 9.5 EUR.
How to purchase AVITA Medical, Inc. stock?
You can buy 51KA.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for AVITA Medical, Inc.?
The stock symbol or ticker of AVITA Medical, Inc. is 51KA.F.
Which industry does the AVITA Medical, Inc. company belong to?
The AVITA Medical, Inc. industry is Medical Devices.
How many shares does AVITA Medical, Inc. have in circulation?
The max supply of AVITA Medical, Inc. shares is 25.71M.
What is AVITA Medical, Inc. Price to Earnings Ratio (PE Ratio)?
AVITA Medical, Inc. PE Ratio is now.
What was AVITA Medical, Inc. earnings per share over the trailing 12 months (TTM)?
AVITA Medical, Inc. EPS is -1.31 EUR over the trailing 12 months.
Which sector does the AVITA Medical, Inc. company belong to?
The AVITA Medical, Inc. sector is Healthcare.